Ambient particulate matter air pollution and venous thromboembolism in the Women's Health Initiative Hormone Therapy trials.
Shih
Regina A
RA
RAND Corporation, Arlington, Virginia 22202, USA. rshih@rand.org
Griffin
Beth Ann
BA
Salkowski
Nicholas
N
Jewell
Adria
A
Eibner
Christine
C
Bird
Chloe E
CE
Liao
Duanping
D
Cushman
Mary
M
Margolis
Helene G
HG
Eaton
Charles B
CB
Whitsel
Eric A
EA
D000368:Aged; D000393:Air Pollutants / Q000032:analysis* / Q000633:toxicity; D000397:Air Pollution / Q000706:statistics & numerical data*; D004347:Drug Interactions; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D019570:Inhalation Exposure / Q000009:adverse effects / Q000706:statistics & numerical data; D008875:Middle Aged; D010316:Particle Size; D052638:Particulate Matter / Q000032:analysis* / Q000633:toxicity; D017698:Postmenopause; D011372:Progestins / Q000627:therapeutic use; D016016:Proportional Hazards Models; D014481:United States; D054556:Venous Thromboembolism / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology; D016387:Women's Health
D000393:Air Pollutants; D004967:Estrogens; D052638:Particulate Matter; D011372:Progestins